- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Surgery in the combination therapies era ; volume:13 ; number:1 ; day:15 ; month:1 ; year:2015 ; pages:1 ; date:12.2015
Journal of translational medicine ; 13, Heft 1 (15.1.2015), 1, 12.2015
- Creator
-
Mozzillo, Nicola
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-13-S1-K11
- URN
-
urn:nbn:de:1111-2016041451456
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mozzillo, Nicola
- SpringerLink (Online service)
Other Objects (12)
Melanoma: the role of surgery in the era of new therapies
FLT3 targeting in the modern era: from clonal selection to combination therapies
Nanomedicine formulations for combination therapies
Combination therapies utilizing neoepitope-targeted vaccines
The future of combination therapies in advanced melanoma
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Melanoma: the role of surgery in the era of new therapies
FLT3 targeting in the modern era: from clonal selection to combination therapies
Nanomedicine formulations for combination therapies
Combination therapies utilizing neoepitope-targeted vaccines
The future of combination therapies in advanced melanoma
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Melanoma: the role of surgery in the era of new therapies
FLT3 targeting in the modern era: from clonal selection to combination therapies
Nanomedicine formulations for combination therapies
Combination therapies utilizing neoepitope-targeted vaccines
The future of combination therapies in advanced melanoma
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies